STATCenter·
STAT+: FDA approves novel Bayer drug to reduce recurrence of stroke
Bayer's drug is the first in a novel class of medications designed to prevent blood clots without increasing risk of bleeding.
Read at STAT →
Health · 1 sources covering this
STAT+: FDA approves novel Bayer drug to reduce recurrence of stroke
Bayer's drug is the first in a novel class of medications designed to prevent blood clots without increasing risk of bleeding.
Coverage spectrum
0 L · 1 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://statesidedaily.com/embed/cluster/d53f1924df0462ee21599e5979cea8d95751da8f" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="STAT+: FDA approves novel Bayer drug to reduce recurrence of stroke"></iframe>
